P4-347: Tau aggregation inhibitor (TAI) therapy with rember™ arrests the trajectory of rCBF decline in brain regions affected by Tau pathology in mild and moderate Alzheimer's disease (AD)
Staff, Roger T., Ahearn, Trevor S., Murray, Alison D., Bentham, Peter, Seng, Kwang Meng, Wischik, ClaudeVolume:
4
Langue:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2008.05.2417
Date:
July, 2008
Fichier:
PDF, 104 KB
english, 2008
File converter
Plus de résultats de recherche
More benefits 
